Rizatriptan Benzoate
Product Images NDC 63629-7433

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 63629-7433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636297433)

This appears to be a prescription label for a medication called Rizatriptan Benzoate, which comes in a pink oval tablet form and is used to treat migraines. The label instructs the patient to store the medication at room temperature and to keep it out of reach of children. There is also information regarding the manufacturer and the NDC number of the medication.*

FDA Label Image

Rizatriptan 01

FDA Label Image

Rizatriptan 02

The text provided seems to be a chart or a graph representing the Estimated Probability of Response of Placebo and Rizatriptan Benzoate Tablets of 5 mg and 10 mg. The probability is presented in percentage and varies from 0-100%. The readability is affected due to the errors, making it difficult to interpret the complete information accurately.*

FDA Label Image

Rizatriptan 03

This appears to be a chart displaying estimated probability of remedication or rescue for Rizatriptan Benzoate Tablets in 5mg and 10mg doses, as well as a placebo. The chart shows percentages at various hours post-dose, ranging from 0 to 20 hours.*

FDA Label Image

Rizatriptan 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.